Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 0.03
NYSE:CYH's Cash to Debt is ranked lower than
91% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. NYSE:CYH: 0.03 )
Ranked among companies with meaningful Cash to Debt only.
NYSE:CYH' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.03 Max: N/A
Current: 0.03
Equity to Asset 0.08
NYSE:CYH's Equity to Asset is ranked lower than
92% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. NYSE:CYH: 0.08 )
Ranked among companies with meaningful Equity to Asset only.
NYSE:CYH' s Equity to Asset Range Over the Past 10 Years
Min: 0.08  Med: 0.17 Max: 0.46
Current: 0.08
0.08
0.46
F-Score: 5
Z-Score: 0.79
M-Score: -3.19
WACC vs ROIC
4.34%
-3.86%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) -3.06
NYSE:CYH's Operating margin (%) is ranked lower than
84% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 6.97 vs. NYSE:CYH: -3.06 )
Ranked among companies with meaningful Operating margin (%) only.
NYSE:CYH' s Operating margin (%) Range Over the Past 10 Years
Min: -3.06  Med: 8.89 Max: 9.55
Current: -3.06
-3.06
9.55
Net-margin (%) -7.55
NYSE:CYH's Net-margin (%) is ranked lower than
88% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 4.69 vs. NYSE:CYH: -7.55 )
Ranked among companies with meaningful Net-margin (%) only.
NYSE:CYH' s Net-margin (%) Range Over the Past 10 Years
Min: -7.55  Med: 1.85 Max: 4.03
Current: -7.55
-7.55
4.03
ROE (%) -39.54
NYSE:CYH's ROE (%) is ranked lower than
96% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 9.37 vs. NYSE:CYH: -39.54 )
Ranked among companies with meaningful ROE (%) only.
NYSE:CYH' s ROE (%) Range Over the Past 10 Years
Min: -39.54  Med: 9.52 Max: 13.65
Current: -39.54
-39.54
13.65
ROA (%) -5.57
NYSE:CYH's ROA (%) is ranked lower than
85% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. NYSE:CYH: -5.57 )
Ranked among companies with meaningful ROA (%) only.
NYSE:CYH' s ROA (%) Range Over the Past 10 Years
Min: -5.57  Med: 1.48 Max: 3.99
Current: -5.57
-5.57
3.99
ROC (Joel Greenblatt) (%) -4.89
NYSE:CYH's ROC (Joel Greenblatt) (%) is ranked lower than
83% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 19.96 vs. NYSE:CYH: -4.89 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NYSE:CYH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -4.89  Med: 14.64 Max: 17.26
Current: -4.89
-4.89
17.26
Revenue Growth (3Y)(%) 5.70
NYSE:CYH's Revenue Growth (3Y)(%) is ranked lower than
59% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 8.00 vs. NYSE:CYH: 5.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
NYSE:CYH' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0.2  Med: 14.5 Max: 47.2
Current: 5.7
0.2
47.2
EBITDA Growth (3Y)(%) 1.50
NYSE:CYH's EBITDA Growth (3Y)(%) is ranked lower than
73% of the 147 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. NYSE:CYH: 1.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NYSE:CYH' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -1.8  Med: 8.45 Max: 45.2
Current: 1.5
-1.8
45.2
EPS Growth (3Y)(%) -18.40
NYSE:CYH's EPS Growth (3Y)(%) is ranked lower than
85% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. NYSE:CYH: -18.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NYSE:CYH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -28.8  Med: 10.8 Max: 110.1
Current: -18.4
-28.8
110.1
» NYSE:CYH's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-11-03)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

CYH Guru Trades in Q3 2015

Pioneer Investments 45,475 sh (New)
Steven Cohen 90,000 sh (New)
Ray Dalio 8,517 sh (New)
Paul Tudor Jones 53,674 sh (+643.00%)
David Dreman 9,769 sh (+172.19%)
Richard Perry 2,467,512 sh (+12.16%)
Larry Robbins 12,093,795 sh (unchged)
Jeff Auxier 34,274 sh (unchged)
Vanguard Health Care Fund Sold Out
Louis Moore Bacon Sold Out
Joel Greenblatt Sold Out
Ron Baron 3,997,990 sh (-2.58%)
Richard Snow 1,784,086 sh (-14.99%)
John Hussman 65,000 sh (-35.00%)
» More
Q4 2015

CYH Guru Trades in Q4 2015

David Tepper 1,000,000 sh (New)
Richard Snow 3,216,127 sh (+80.27%)
Jeff Auxier 36,436 sh (+6.31%)
Steven Cohen 150,000 sh (unchged)
Samuel Isaly 595,000 sh (unchged)
Pioneer Investments Sold Out
David Dreman Sold Out
Ray Dalio Sold Out
Steven Cohen Sold Out
John Hussman Sold Out
Larry Robbins 11,593,795 sh (-4.13%)
Richard Perry 2,332,086 sh (-5.49%)
Ron Baron 1,608,288 sh (-59.77%)
Paul Tudor Jones 10,238 sh (-80.93%)
» More
Q1 2016

CYH Guru Trades in Q1 2016

David Dreman 7,610 sh (New)
Jim Simons 1,029,393 sh (New)
David Einhorn 1,122,932 sh (New)
David Tepper 7,150,000 sh (+615.00%)
Richard Snow 3,514,388 sh (+9.27%)
John Paulson 350,000 sh (unchged)
Paul Tudor Jones Sold Out
Larry Robbins Sold Out
Richard Perry Sold Out
Jeff Auxier 36,416 sh (-0.05%)
Ron Baron 100 sh (-99.99%)
Samuel Isaly 336,400 sh (-43.46%)
» More
Q2 2016

CYH Guru Trades in Q2 2016

Jeremy Grantham 600,000 sh (New)
Ronald Muhlenkamp 377,245 sh (New)
David Einhorn 2,419,017 sh (+115.42%)
Richard Snow 3,789,599 sh (+7.83%)
John Paulson 880,000 sh (unchged)
Ron Baron 100 sh (unchged)
Jim Simons Sold Out
Samuel Isaly Sold Out
David Tepper 6,270,130 sh (-12.31%)
Jeff Auxier 26,134 sh (-28.23%)
David Dreman 566 sh (-92.56%)
» More
» Details

Insider Trades

Latest Guru Trades with CYH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:NAS:PAHC, NYSE:ADPT, NAS:SGRY, NAS:HWAY, NYSE:USPH, NYSE:AHS, NAS:AMED, NAS:LHCG, NAS:PRSC, NYSE:SEM, NAS:SCAI, OTCPK:MFCSF, NYSE:AAC, NAS:AFAM, NAS:BIOS, NAS:ADUS, AMEX:HLTH, NAS:USMD, NYSE:QHC, NYSE:CCM » details
Traded in other countries:CG5.Germany,
Community Health Systems Inc provides healthcare services through the hospitals that it owns and operates in non-urban and selected urban markets throughout the United States.

Community Health Systems Inc was originally founded in 1986 and was reincorporated in 1996 as a Delaware corporation. The Company operates general acute care hospitals in communities across the country. It provides healthcare services through the hospitals that it own & operate and affiliated businesses in non-urban and selected urban markets throughout the United States. The company provides general and specialized hospital healthcare services and other outpatient services to patients in the communities. The services provided through its hospitals and affiliated businesses include general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric and rehabilitation services. It also provides additional outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers and home health and hospice agencies. In addition to its hospitals and related businesses, the company also owns and operates 79 licensed home care agencies and 22 licensed hospice agencies located in markets where it also operates a hospital. Also, through its wholly-owned subsidiary, Quorum Health Resources, LLC, or QHR, the company provides management and consulting services to non-affiliated general acute care hospitals located throughout the United States. For the services it provide through hospitals and home care agencies that it owns and operates, the company is paid by governmental agencies, private insurers and directly by the patients it serve. The Company is subject to various federal, state and local laws and regulations governing the use, discharge and disposal of hazardous materials, including medical and pharmaceutical waste products.

Ratios

vs
industry
vs
history
Forward P/E 4.94
CYH's Forward P/E is ranked higher than
98% of the 66 Companies
in the Global Medical Care industry.

( Industry Median: 17.86 vs. CYH: 4.94 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 0.69
CYH's P/B is ranked higher than
96% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. CYH: 0.69 )
Ranked among companies with meaningful P/B only.
CYH' s P/B Range Over the Past 10 Years
Min: 0.34  Med: 1.2 Max: 2.12
Current: 0.69
0.34
2.12
P/S 0.06
CYH's P/S is ranked higher than
99% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 1.50 vs. CYH: 0.06 )
Ranked among companies with meaningful P/S only.
CYH' s P/S Range Over the Past 10 Years
Min: 0.06  Med: 0.24 Max: 0.92
Current: 0.06
0.06
0.92
PFCF 52.63
CYH's PFCF is ranked lower than
77% of the 110 Companies
in the Global Medical Care industry.

( Industry Median: 22.61 vs. CYH: 52.63 )
Ranked among companies with meaningful PFCF only.
CYH' s PFCF Range Over the Past 10 Years
Min: 0.12  Med: 9.64 Max: 1750.56
Current: 52.63
0.12
1750.56
POCF 1.17
CYH's POCF is ranked higher than
99% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 14.37 vs. CYH: 1.17 )
Ranked among companies with meaningful POCF only.
CYH' s POCF Range Over the Past 10 Years
Min: 0.86  Med: 2.74 Max: 9.33
Current: 1.17
0.86
9.33
EV-to-EBITDA 28.51
CYH's EV-to-EBITDA is ranked lower than
81% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 14.64 vs. CYH: 28.51 )
Ranked among companies with meaningful EV-to-EBITDA only.
CYH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.4  Med: 7.6 Max: 29
Current: 28.51
5.4
29
Shiller P/E 17.52
CYH's Shiller P/E is ranked higher than
79% of the 47 Companies
in the Global Medical Care industry.

( Industry Median: 28.53 vs. CYH: 17.52 )
Ranked among companies with meaningful Shiller P/E only.
CYH' s Shiller P/E Range Over the Past 10 Years
Min: 5.98  Med: 15.89 Max: 24.29
Current: 17.52
5.98
24.29
Current Ratio 1.77
CYH's Current Ratio is ranked higher than
67% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. CYH: 1.77 )
Ranked among companies with meaningful Current Ratio only.
CYH' s Current Ratio Range Over the Past 10 Years
Min: 1.48  Med: 1.76 Max: 2.34
Current: 1.77
1.48
2.34
Quick Ratio 1.58
CYH's Quick Ratio is ranked higher than
65% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. CYH: 1.58 )
Ranked among companies with meaningful Quick Ratio only.
CYH' s Quick Ratio Range Over the Past 10 Years
Min: 1.31  Med: 1.56 Max: 2.14
Current: 1.58
1.31
2.14
Days Inventory 66.87
CYH's Days Inventory is ranked lower than
83% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. CYH: 66.87 )
Ranked among companies with meaningful Days Inventory only.
CYH' s Days Inventory Range Over the Past 10 Years
Min: 17.7  Med: 65.26 Max: 68.3
Current: 66.87
17.7
68.3
Days Sales Outstanding 60.33
CYH's Days Sales Outstanding is ranked lower than
70% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 43.71 vs. CYH: 60.33 )
Ranked among companies with meaningful Days Sales Outstanding only.
CYH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.58  Med: 62.47 Max: 78.9
Current: 60.33
49.58
78.9
Days Payable 115.49
CYH's Days Payable is ranked higher than
78% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. CYH: 115.49 )
Ranked among companies with meaningful Days Payable only.
CYH' s Days Payable Range Over the Past 10 Years
Min: 42.07  Med: 138 Max: 175.38
Current: 115.49
42.07
175.38

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -7.00
CYH's 3-Year Average Share Buyback Ratio is ranked lower than
70% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. CYH: -7.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CYH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -21.9  Med: 0.35 Max: 3.8
Current: -7
-21.9
3.8

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.27
CYH's Price/Median PS Value is ranked higher than
99% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. CYH: 0.27 )
Ranked among companies with meaningful Price/Median PS Value only.
CYH' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.25  Med: 1.23 Max: 6.68
Current: 0.27
0.25
6.68
Earnings Yield (Greenblatt) (%) -3.59
CYH's Earnings Yield (Greenblatt) (%) is ranked lower than
85% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. CYH: -3.59 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CYH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -3.62  Med: 8.4 Max: 12
Current: -3.59
-3.62
12
Forward Rate of Return (Yacktman) (%) -23.19
CYH's Forward Rate of Return (Yacktman) (%) is ranked lower than
94% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 10.20 vs. CYH: -23.19 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CYH' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -43.6  Med: 16.5 Max: 84.5
Current: -23.19
-43.6
84.5

More Statistics

Revenue (TTM) (Mil) $19,233
EPS (TTM) $ -13.08
Beta0.57
Short Percentage of Float32.10%
52-Week Range $9.67 - 37.41
Shares Outstanding (Mil)113.64

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 19,649 18,108 19,504
EPS ($) 1.94 2.07 2.73
EPS w/o NRI ($) 1.94 2.07 2.73
EPS Growth Rate
(3Y to 5Y Estimate)
12.00%
Dividends Per Share ($)
» More Articles for NYSE:CYH

Headlines

Articles On GuruFocus.com
3 Companies Fall to 52-Week Lows Aug 17 2016 
Ron Baron Trims Nearly 180 Stakes in 4th Quarter Feb 19 2016 
Baron Funds Comments on Community Health Systems Feb 05 2016 
Baron Funds Comments on Community Health Systems Inc. Nov 10 2015 
Larry Robbins Reduces Position in Community Health Systems Oct 28 2015 
Richard Perry Invests in Williams Companies Aug 23 2015 
Baron Funds Comments on Community Health Systems Inc. Aug 18 2015 
2015 – The Year Of Health And Wellness Stocks Jan 19 2015 
Baron Growth Fund Comments on Community Health Systems Inc Oct 24 2014 
Ron Baron’s Baron Growth Fund Q3 2014 Report Oct 24 2014 

More From Other Websites
2 Oversold Health Care Service Stocks in Wake of Community Health Review Sep 23 2016
Struggling Hospital Cos. Quorum, LifePoint Next Up in Consolidation Push Sep 23 2016
As CHS considers a sale, future uncertain for CEO Wayne Smith Sep 22 2016
Apollo's 2016 M&A Frenzy Continues Sep 20 2016
Report: Fund with existing area health care ties eyes CHS assets Sep 20 2016
Community Health Systems, Inc. – Value Analysis (NYSE:CYH) : September 20, 2016 Sep 20 2016
Community Health Draws Interest as Hospital Sector Appears Ripe for LBO Wave Sep 20 2016
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Lawsuit Filed Against Quorum Health... Sep 20 2016
Is Community Health due for pullback? Sep 20 2016
Community Health (CYH) Stock Advances, Exploring Options Sep 20 2016
GM Bulls Out in Force, Oclaro Makes Offering, Plus 3 More Trending Stocks Sep 20 2016
[$$] Community Health Systems Exploring Alternatives Sep 19 2016
Who might buy Community Health Systems (and who probably won't) Sep 19 2016
Community Health May Go Under the Knife Sep 19 2016
TerraForm Power Inc (TERP) and Three Other Stocks Trading Higher on Positive News; Community Health... Sep 19 2016
Community Health is Selling But Who's Buying? Sep 19 2016
Community Health May Be Planning Sale Sep 19 2016
Community Health Systems (CYH) Stock Falls, Exploring Alternatives Sep 19 2016
[$$] Community Health Systems Exploring Alternatives Sep 19 2016
Stocks to Watch: Isle of Capri Casinos, Community Health Systems, Infoblox Sep 19 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)